Form D · Biotechnology
GITR Inc.
Cambridge, MA · CIK 0001538316
Offering snapshot reported May 8, 2015 · SEC filing
- Reported sold
- $1.5M Offering amount: $18.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 24, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 8, 2015 | Initial | $1,500,000 | No comparison | 1 | SEC filing |
| Dec 21, 2012 | Amendment | $3,250,000 | $2,000,000vs Jan 4, 2012 | 1 | SEC filing |
| Jun 12, 2012 | Amendment | $2,250,000 | $1,000,000vs Jan 4, 2012 | 1 | SEC filing |
| Jan 4, 2012 | Initial | $1,250,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-239513
Series A Preferred Stock that may be converted into common stock.
Source: Form D, filed May 8, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Augustine Lawlor | Director, Executive |
| Jeffrey Steinberg | Director, Executive |
| Robert Steinberg | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
C/O Health Care Ventures Llc 47 Thorndike Street, Suite B1 1
Cambridge, MA, 02141
Cambridge, MA, 02141